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Bacterial or viral infection of the mother during the course of pregnancy can cross the placenta and actively infect 
the fetus. However, especially for bacteria, it is more common for mothers to experience an infection that can be 
treated without overt fetal infection. In this setting, it is less well understood what the risk to fetal development is, 
particularly in terms of neurological development. This research highlight reviews recent findings indicating that 
bacterial components generated during infection of the mother can cross the placenta and activate the fetal innate 
immune system resulting in changes in the course of brain development and subsequent progression to postnatal 
cognitive disorders. Bacterial cell wall is a ubiquitous bacterial PAMP (pathogen-associated molecular pattern) 
known to activate inflammation through the stimulation of TLR2. Cell wall is released from bacteria during 
antibiotic treatment and new work shows that embryos exposed to cell wall from the mother demonstrate 
anomalous proliferation of neuronal precursor cells in a TLR2 dependent manner. Such proliferation increases 
the neuronal density of the cortical plate and alters brain architecture. Although there is no fetal death, subsequent 
cognitive development is significantly impaired. This model system suggests that bacterial infection of the mother 
and its treatment can impact fetal brain development and requires greater understanding to potentially eliminate 
a risk factor for cognitive disorders such as autism. 
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During pregnancy, infection and inflammation can pose a 
threat to the health and development of the fetus [3, 14, 24]. 
While the ability of a number of bacterial and viral pathogens 
to cross the placental barrier and cause harm to the 
development of the fetus is known, less well studied is the 
impact that bacterial components tracking from the maternal 
blood stream to the fetus have on development. Microbial 
products circulate not only in active infection but also 
normally when released from the gut microbiome [5]. In this 
emerging field, new evidence suggests the mother’s intestinal 
microbiota during pregnancy influences early innate immune 
responses in her offspring. Gomez de Aguero et al found that 
specific bacterial metabolites from the mother’s microbiome 
induce the development of the ILC3-IL-22 antimicrobial 
system in the fetus [10]. This was the first report definitively 
showing the role of the mother’s microbiome on fetal 
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development in utero. Further evidence suggests that changes 
in maternal cytokine profiles, gut microbial dysbiosis and even 
bacterial metabolites and fragments crossing the placenta 
induce fetal responses [4, 10, 11]. Not all interactions with 
bacterial products at the maternal-fetal interface are positive. 
This research highlight focuses on the ability of cell wall, a 
universal component of bacteria, to cross the placenta and 
disrupt the normal development of the murine fetal brain, 
resulting in cognitive disorders after birth [11]. 
 
Pathogen associated molecular patterns (PAMPs) are 
recognized by the innate immune system as an early sign of 
infection. In the case of the Gram positive pathogen 
Streptococcus pneumoniae, a major PAMP is the cell wall 
(CW) which triggers innate immune responses through toll 
like receptor 2 (TLR2) [12, 27]. S. pneumoniae is a leading cause 
of infant and adult bacterial sepsis and meningitis, a serious 
infection leading to significant brain damage even when 
treated.  In animal models, bacterial CW is sufficient  to induce 
the entire symptom complex of meningitis [25, 26]. It can traffic 
across the blood brain barrier and trigger inflammation and 
neuronal death [2, 8, 20]. Much like the blood brain barrier, the 
placenta acts as a physical barrier between the mother and the 
immune privileged embryo, thereby protecting against 
invading pathogens and the mother’s immune system. 
Pathogens that are able to infect the fetus and disrupt 
development share the ability to cross the placental barrier [22]. 
However, the ability of bacterial components to cross the 
placenta has not been well studied. Given that CW fragments 
can cross the blood brain barrier in postnatal models, we 
reasoned that CW exposure to pregnant mice would be a good 
model to assess the impact of sterile bacterial products on the 
developing fetal brain. 
 
CW silently crosses the placenta and fetal blood brain 
barrier 
 
To model the circulation of bacterial products during 
infection, FITC labelled CW was injected intravenously into 
pregnant dams and followed by microscopy for accumulation 
in the placenta and fetal brain. CW crossed the placenta 
without significant inflammation, cell death or placental 
dysfunction [11]. Within 24 hours, CW accumulated in the fetal 
brain.  The translocation process across the placenta and the 
fetal blood brain barrier was mediated by the platelet 
activating factor receptor (PAFr). PAFr binds the chemokine 
PAF but by molecular mimicry also binds and transports 
components of most respiratory pathogens that decorate their 
surface with phosphorylcholine [6]. This implies that 
components of many bacteria can easily cross to the 
developing fetus. 
 
It is well known that CW causes inflammation and cell 
death in postnatal animal models [2, 8, 20, 25]. Surprisingly, the 
accumulation of the CW in the fetal brain elicited very little 
neuronal death or influx of inflammatory cells. Rather the fetal 
brain responded by proliferation of neuronal precursor cells 
(NPCs) leading to a 50% increase in the density of cells at the 
cortical plate [11]. NPC proliferation in response to CW was 
recapitulated in vitro using primary murine NPCs. This 
phenotype both in vitro and in vivo was TLR2 dependent as 
transgenic mice lacking TLR2 did not show fetal 
neuroproliferation. 
 
The mechanism of CW induced neuroproliferation 
 
Neuroproliferation of NPCs appears to involve activation 
of the neuronal transcription factor FoxG1. Forkhead box 
protein G1 (FoxG1) is important in early development [16] and 
is embryonic lethal when knocked out [9]. Mutations in the 
FOXG1 gene are the cause of FOXG1 syndrome, a condition 
consisting of developmental and structural brain abnormalities 
[13]. In pre-natal brains, exposure to CW led to a significant 
increase in FoxG1 expression in a TLR2 dependent manner 
[11]. This indicates a previously unknown link may exist 
between innate immunity (TLR2 activation) and 
neurodevelopment (FoxG1 expression). 
 
Using the in vitro model of NPC proliferation induced by 
CW, distinction could be made as to activation of the partners 
for TLR2: e.g. heterodimer TLR2/6 or TLR1/2 [11]. Synthetic 
agonists of TLR2/6 but not TLR2/1 caused neuroproliferation 
suggesting that CW induced signaling may be restricted to a 
specific arm of the classical innate immune response pathway. 
Currently both TLR2 heterodimers are thought to signal 
through the adapter molecule MyD88 and end in NF-κB 
activation leading to the release of inflammatory cytokines [19]. 
If both receptors do in fact signal through the same pathway, 
it suggests that a second signal or novel pathway may exist to 
change the outcome from neuronal death with inflammation to 
neuroproliferation. The literature on the TLR1/2 complex is 
far more complete than that of the TLR2/6 heterodimer 
suggesting this may be a good model for further elucidation of 
the TLR2/6 signaling cascade. Of particular interest in this 
model is the role of PI3K-AKT to the neuroproliferation 
pathway. During neuroproliferation there was an increase in 
p-AKT and PI3Kinase both of which are in the FoxG1 
signaling cascade [23]. Furthermore hyperactivation of the 
PI3K-AKT pathway leads to a mislocation of neurons through 
a pathway involving FoxG1 [1]. Mislocation of neurons is not 
unlike the phenotype observed in response to CW exposure 
indicating a possible relationship between increased PI3K-
AKT and the FoxG1 overexpression phenotype. 
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In the brain, immune surveillance is carried out by the 
resident macrophages, the microglial cells [21]. Microglial 
activation marker, Iba-1, which is strongly upregulated in the 
adult brain in response to CW, was decreased in the CW 
exposed fetal brain. This suggests that the CW either does not 
activate microglia in the fetal brain or leads to loss of 
microglia. The microglia play an important role during neural 
development in regulating the NPC population density
[7]
.  
Potential  loss  or  lack  of  activation  of  microglia  in 
response to CW exposure may contribute to the proliferation 
of the NPCs in the fetal brain; however this remains to be 
determined. 
 
Postnatal cognitive impairment 
 
The prenatal neuroproliferation and increased cortical plate 
cell density induced by CW did not result in fetal death or 
apparent abnormalities at birth. However, when examined 
over time after birth, pups exposed to CW gained less weight 
and at 3 months of age showed significant behavioral 
abnormalities [11]. Pups showed less exploration, impaired 
memory, and more isolation. These abnormalities showed a 
time dependence in that only CW exposure between E10 and 
E15 resulted in abnormal brain architecture and cognitive 
impairment. Given that genetic studies show a link between 
increased expression of FoxG1 and autism [15], and given 
disruption of microglial development has also been linked to 
autism [17], further studies to define the spectrum of CW 




Bacterial products circulating in the blood stream are 
released in an explosive manner when bacteria are killed by 
CW-active antibiotics, such as the β lactams. [18]. In animal 
models and human infection, treatment with β lactams such as 
ampicillin is accompanied by a burst of inflammation as a 
result of abrupt release of bacterial products into the 
surrounding tissues or the bloodstream [25, 26]. We reasoned 
that CW released during antibiotic treatment of maternal 
infection may also lead to abnormal fetal brain architecture. 
When pregnant dams were infected with living S. pneumoniae 
and cured by treatment daily for five days with ampicillin, 
embryos showed the predicted significant increase in cell 
density at the cortical plate as observed when challenged with 
purified CW [11]. Importantly when the infected mother was 
treated with clindamycin, a protein synthesis inhibitor that 
does not release CW, there was no increase in the cortical plate 
cell density. The findings of this study could have important 
clinical implications for the choice of antibiotics for treatment 
of suspected infection during pregnancy. 
Future studies 
 
Given the emerging findings of the effect of microbial 
products on fetal development, this will be an important area 
for future studies of pathophysiology at maternal fetal 
interface. Questions raised include the mechanisms of 
alteration of fetal development by activation of innate immune 
signaling. The interacting pathways appear to crosstalk 
differently over the course of pregnancy and to switch 
completely around the time of birth. The details of the 
differential effect of CW on neurons pre- and postnatally 
suggest a route to potentially develop novel therapeutics to 
block the inflammatory pathway observed in the postnatal 
setting and encourage new neuronal development to mitigate 
the devastating effects of meningitis. On the other hand, 
preventing neuroproliferation in the fetus may lower the 
incidence of postnatal developmental disorders. 
Epidemiological studies support a link between fever, FoxG1 
and autism spectrum which may be further explored by this 
model [3, 14]. Questions about CW release from antibiotic 
treatment of maternal infection or the microbiome may lead to 




The study of Humann et al [11] highlights that bacterial 
subcomponents and not just living bacteria can pose a threat 
to the fetus during gestation. There is a need to take into 
account the effects of bacterial metabolites and byproducts in 
the blood during pregnancy on fetal development. Therefore, 
consideration of how to treat maternal infection may need to 
include an assessment of how components released during 
death of the infecting organism impacts the developing fetus. 
This model revealed the role of innate immune signaling by 
TLR2 during embryogenesis and the potential to modulate 
responses to prevent both abnormal neuroproliferation and 
neuronal death in response to bacterial products. This study 
focused on the TLR2 PAMP, bacterial CW, but the release of 
bacterial products into the maternal bloodstream from other 
species of bacteria may also effect fetal development. This 
emerging field will foster new understanding in fetal brain 
development, fetal immune development, interactions 
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